Dr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.
Dr. Hersh and colleagues have begun to analyze data from their patients who underwent CXL as part of an FDA clinical trial in order to devise a CXL algorithm. The article below was published in the June 1, 2012 issue of Ophthalmology Times.